Solar cells
    51.
    发明授权

    公开(公告)号:US11257967B2

    公开(公告)日:2022-02-22

    申请号:US16504868

    申请日:2019-07-08

    Abstract: A composition of matter, in particular a photovoltaic cell, comprising: at least one core semiconductor nanowire on a graphitic substrate, said at least one core nanowire having been grown epitaxially on said substrate wherein said nanowire comprises at least one group III-V compound or at least one group II-VI compound or at least one group IV element; a semiconductor shell surrounding said core nanowire, said shell comprising at least one group III-V compound or at least one group II-VI compound or at least one group IV element such that said core nanowire and said shell form a n-type semiconductor and a p-type semiconductor respectively or vice versa; and an outer conducting coating surrounding said shell which forms an electrode contact.

    Method and Apparatus for Calibrating an Instrument for Surgical Intervention

    公开(公告)号:US20210322107A1

    公开(公告)日:2021-10-21

    申请号:US17272451

    申请日:2019-09-13

    Abstract: A method of calibrating an instrument for surgical intervention is provided. The instrument to be calibrated has a tip at a distal end thereof and a navigation array that is spaced from the distal end and is detectable in space. The navigation array has a fixed spatial and angular relationship with the tip. The method comprises the steps of: placing a calibrator on the tip of the instrument such that the tip is positioned within the calibrator at a known displacement from the centre of the calibrator, the calibrator having a circular shape and being detectable as a single point in space; detecting the position of the navigation array and the centre of the calibrator; and determining the position of the centre of the calibrator relative to the navigation array, thereby calibrating the position of the tip of the instrument relative to the navigation array. There is also provided a calibrator for use in such a method.

    Immunosuppressive agents and their use in therapy

    公开(公告)号:US10517923B2

    公开(公告)日:2019-12-31

    申请号:US15034917

    申请日:2014-11-06

    Inventor: Marit Otterlei

    Abstract: The present invention provides an agent, or composition containing an agent, for use in treating or preventing hypercytokinemia in a subject resulting from cytokine release from non-proliferating immune cells in blood, wherein the agent comprises: (i) an oligopeptidic compound comprising a PCNA interacting motif and a domain that facilitates the cellular uptake of said compound, wherein the PCNA interacting motif is X1X2X3X4X5 (SEQ ID NO: 1) and wherein: X1 is a basic amino acid; X2 is an aromatic amino acid; X3 is an uncharged amino acid other than an aromatic amino acid, Glycine (G) and Proline (P); X4 is any amino acid other than Proline (P), an acidic amino acid or an aromatic amino acid; and X5 is a basic amino acid or Proline (P); or (ii) a nucleic acid molecule comprising a sequence encoding the oligopeptidic compound of (i). In certain aspects the agent and compositions of the invention may be used as single agents. In other aspects of the invention agents and compositions of the invention may be used in conjunction with one or more additional active agents, such as kinase inhibitors.

    IONIC GEL
    59.
    发明申请
    IONIC GEL 审中-公开
    离子凝胶

    公开(公告)号:US20150126619A1

    公开(公告)日:2015-05-07

    申请号:US14344929

    申请日:2012-09-14

    Abstract: A process for the formation of an ionic gel comprising contacting a first polyelectrolyte reactant having a backbone comprising a plurality of β-1,4-glycosidic linkages in the 4C1 conformation and an oligoelectrolyte reactant or second polyelectrolyte reactant, having a backbone containing a plurality of β-1,4-glycosidic linkages in the 4C1 conformation, in aqueous solution under pH conditions such that one reactant is charged and the other uncharged; adding a donor to adjust the pH such that said uncharged reactant possesses a charge opposite to that of the charged reactant so as to form an ionic gel.

    Abstract translation: 一种用于形成离子凝胶的方法,其包括使具有包含多个4c1-构象中的多个& bgr--1,4-糖苷键的主链的第一聚电解质反应物和具有包含多个的主链的寡电解质反应物或第二聚电解质反应物 在4C1构象中,在pH条件下的水溶液中使一个反应物充电,另一个不带电; 加入供体以调节pH,使得所述不带电荷的反应物具有与加入的反应物相反的电荷,以形成离子凝胶。

Patent Agency Ranking